Govt may soon tweak PLI scheme for pharma

Published On 2023-09-20 10:45 GMT   |   Update On 2023-09-20 10:45 GMT
Advertisement

New Delhi: The government may soon tweak the production-linked incentive scheme for pharmaceuticals, drones and textiles sectors to encourage investment and boost manufacturing, an official said.

These sectors have been identified after inter-ministerial consultations on the performance of the scheme for various products.

The official also said that disbursement of production-linked incentives for white goods (air conditioner and LED lights) would start this month and that would push the amount of disbursement, which was only Rs 2,900 crore till March 2023.

Advertisement

The scheme was announced in 2021 for 14 sectors such as telecommunications, white goods, textiles, manufacturing of medical devices, automobiles, speciality steel, food products, high-efficiency solar PV modules, advanced chemistry cell battery, drones and pharma with an outlay of Rs 1.97 lakh crore.

'We have identified the sectors. We are going to send the combined note to seek approval of the Union Cabinet. The changes include extending some time (for pharma sector) and adding some additional products in some sectors.

'In textiles, we are expanding the definition of certain other products in the technical textiles segment; in drones, we are increasing the amount,' the government official, who did not wish to be named said.

The total amount allocated for the PLI scheme for drones and drone components is Rs 120 crore spread over three financial years.

A senior official of the commerce and industry ministry had earlier stated that some course corrections or tweaking were needed in PLI schemes that were not doing well.

PLI schemes for sectors which are not picking up well include high-efficiency solar PV modules, advanced chemistry cell batteries, textile products and speciality steel.

On the other hand, the scheme is doing well in sectors such as electronics, pharma, medical devices, telecom, food processing, and white goods.

The government is trying to sort out issues such as timely processing of claims, visa-related matters where vendors require Chinese professionals' expertise, and delay in getting environmental clearances that have been raised by certain stakeholders of PLI schemes.

The purpose of the scheme is to attract investments in key sectors and cutting-edge technology; ensure efficiency and bring economies of size and scale in the manufacturing sector; and make Indian companies and manufacturers globally competitive.

These schemes for all 14 sectors have been notified by the concerned ministries/ departments after due approval. These schemes are in various stages of implementation.

The government is expected to disburse about Rs 13,000 crore to eligible firms seeking benefits under the schemes

Read also: India set to become global hub of medical technology, devices with the market size estimated to reach USD 50 billion by 2050: Dr Mandaviya

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News